| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963760 | Vaccine | 2015 | 15 Pages |
Abstract
While the pipeline of influenza vaccines appears to be moving towards a variety of niche products in the near term, it is apparent that the ultimate aim remains the development of effective “universal” influenza vaccines that offer longer-lasting immunity against a broad range of influenza A subtypes.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
William K. Ampofo, Eduardo Azziz-Baumgartner, Uzma Bashir, Nancy J. Cox, Rodrigo Fasce, Maria Giovanni, Gary Grohmann, Sue Huang, Jackie Katz, Alla Mironenko, Talat Mokhtari-Azad, Pretty Multihartina Sasono, Mahmudur Rahman, Pathom Sawanpanyalert,